Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Visualizações
• 07/09/23
0
0
Embutir
administrator
Assinantes
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários